Why the study?
Are circulating lipoprotein subfractions associated with lipid content in coronary atheromatous plaques in statin-treated patients with stable CAD?
Population
56 statin-treated patients with stable coronary artery disease undergoing percutaneous coronary intervention
Design
Cross-sectional
Key result
Circulating Lp(a) (78.1% presence in resampled datasets) and free cholesterol in the smallest HDL subfractions (74.3%) showed modest potential as predictors for coronary plaque lipid content.
Authors
Loading...
Lipoprotein subfractions may reflect coronary plaque lipid content in stable CAD; hypothesis-generating for refined risk assessment pending prospective validation.
Observational (n=56)
Are circulating lipoprotein subfractions associated with lipid content in coronary atheromatous plaques in statin-treated patients with stable CAD?
Circulating lipoprotein subfractions provide modest information regarding coronary plaque lipid content, but do not add predictive value beyond established cardiovascular risk factors.
Sæther et al. (2023) conducted an observational in Stable coronary artery disease (n=56). Circulating lipoprotein subfractions was evaluated on Maximum lipid core burden index within any 4 mm length (maxLCBI4mm). Circulating Lp(a) (78.1% presence in resampled datasets) and free cholesterol in the smallest HDL subfractions (74.3%) showed modest potential as predictors for coronary plaque lipid content.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: